Early combination therapy could translate into fewer downstream hospitalizations and lower costs associated with dialysis and cardiovascular complications.

It will be adapting antibody-drug conjugates which it developed for cancer treatment to target these diseases.  Read more at ...

The countdown is on with Argenica’s phase II trial results of lead drug ARG-007 in acute ischaemic stroke patients forecast .

Studying dogs and cancer is a way to learn about cancer in people. It’s not that dogs and owners share exposures to ...

A professor has said how he is 'impressed' with tests carried out on lab mice that could prove groundbreaking in the race for a cure.

In a major advance for patients with Crohn’s disease, a new study led by researchers at Mount Sinai Health System found that ...

Discover the latest breakthroughs in oncology, including FDA approvals and innovative therapies reshaping cancer treatment ...

The uncertainty surrounds who will be able to get updated vaccines in coming months – shots created to protect against more ...